Keytruda
Recently, concerns have emerged in India over a black market for Keytruda, driven by high costs and limited access.
- Keytruda is the brand name of pembrolizumab, an advanced cancer immunotherapy drug.
- Developed by Merck & Co., it is among the world’s top-selling cancer drugs.
- It belongs to a class called checkpoint inhibitors, which enhance immune response against cancer.
- Works by blocking PD-1 receptors on T-cells, preventing cancer cells from evading immune detection.
- Enables the body’s immune system to identify and destroy cancer cells more effectively.
- Used to treat cancers like lung, melanoma, cervical, kidney, and certain breast cancers.
- Unlike chemotherapy, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Ocean Thermal Energy Conversion (OTEC) Project in Lakshadweep
- 2 India Establishes Pilot Plant for Rare Earth Magnets at ARCI
- 3 NavIC Satellite IRNSS-1F Loses Atomic Clock
- 4 India Tests Indigenous Floating LiDAR Buoy System
- 5 DRDO Tests Indigenous Air Droppable Container ADC-150
- 6 INS Anjadip Commissioned
- 7 Indian Army Expands Pinaka Rocket Artillery Regiments
- 8 Minor Planet Centre Announces Discovery of 15 New Moons
- 9 ISRO Tests Upgraded CE20 Cryogenic Engine for LVM3
- 10 Scientists Detect Magnetic Waves Deep Inside the Sun
